コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 To compare the visual and refractive outcomes of femtosecond
6 alyses, source localization and measure projection analyses to compare neural oscillations between individuals with cLBP
7 to characterize the nanoemulsion of anise seed extract and to compare its efficacy with the bulk extract against pathoge
8 y or followed by sorafenib, is noninferior to sorafenib and to compare safety profiles for patients with advanced HCC.
9 -based population with acute loss of smell and/or taste and to compare the frequency of COVID-19 associated symptoms in p
10 er the receiver operating characteristic curve was assessed to compare prognostic accuracy between models with and withou
11 tool along with other indicators of nutrient availability, to compare the background nutrient status across temperate an
13 Elastic network models were constructed to compare the dynamics of tropoelastin and fibrillin individ
14 This pharmacoepidemiology study uses US pharmacy data to compare prescriptions for hydroxychloroquine/chloroquine a
16 aureus bacteremia (SAB) and gram-negative bacteremia (GNB) to compare the characteristics, outcomes, and chemokine and c
20 Here, we use single-molecule optical tweezers measurements to compare translocation of phage, plasmid, and synthetic A-p
21 We used amplicon targeted metagenomics to compare microbial communities from EDC and sputum samples
23 nd secondary end points were assessed in a hierarchic model to compare the regimens and pick the winner.
26 ifies risk with explicit uncertainty estimates, enables one to compare risks over large geographic areas, and produces in
27 , along with subgroup analyses of >=75% compliant patients, to compare the incidence of acute mucositis (Radiation Therap
29 ow-exacerbation groups and then used statistical regression to compare this VDP threshold against conventional clinical m
31 the range of peptide studies done with VCD and extends them to compare with example protein and ROA applications.
32 ing on FUS mutants in parallel to FUS knockout, allowing us to compare mutation-induced changes to genuine loss of functi
33 odelled within the Bass diffusion framework that enables us to compare the differential equation version with an agent-ba
34 errupted Time Series and Difference-in-Difference) are used to compare staff sickness rates before and after the implemen
38 ranslating ribosome affinity purification and qPCR was used to compare mRNA expression of nrg1,2,3,4 and erbB1,2,3,4 in P
39 Cox proportional hazards modeling was used to compare outcomes including death, all-cause stroke, ischem
41 n of clinically meaningful specificity (85%-100%) were used to compare the ability of each output to discriminate eyes wi
42 representative of mono- and disulfated peptides, were used to compare the enrichment capabilities of five sorbent materi
43 from symptom onset [DSO], >=18 years of age) were utilized to compare Veritor with the Lyra SARS-CoV-2 PCR assay (Lyra).
46 The main objective of this study was to compare bioactive compounds and other important quality pa
49 The aim of this retrospective study was to compare the efficacy and safety profile of a single XEN-mi